The protean presentations of XK disease (McLeod syndrome): a case series with new observations and updates on previously reported families

XK disease is a very rare, multi-system disease, which can present with a wide spectrum of symptoms. This disorder can also be identified pre-symptomatically with the incidental detection of serological abnormalities when typing erythrocytes in peripheral blood, or on other routine laboratory testing. Increasing awareness of this disorder and improved access to genetic testing are resulting in increasing identification of affected patients and families. Here we provide updates to some previously-reported families and patients and provide additional clinical details. We also report four new cases with a variety of presentations, one of whom had a novel mutation.

Authors

Institutions

Publication Details

Journal
Frontiers in Neuroscience
Published
2024-09-09
DOI
https://doi.org/10.3389/fnins.2024.1408105
Citations
2
Primary Topic
Erythrocyte Function and Pathophysiology
Type
article
Field-Weighted Citation Impact
0.65
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The protean presentations of XK disease (McLeod syndrome): a case series with new observations and updates on previously reported families

Ruth Helen Walker, Eduardo Meyer, Sunitha Vege, M. Leonor Bustamante et al.
2 citations
Frontiers in Neuroscience
Erythrocyte Function and Pathophysiology
0.65
article

The protean presentations of XK disease (McLeod syndrome): a case series with new observations and updates on previously reported families

Ruth Helen Walker, Eduardo Meyer, Sunitha Vege, M. Leonor Bustamante, Beat M. Frey, Mariana Barreto, Connie M. Westhoff, Martin Paucar, James R. Bateman, Esther Sammler, Scott Feitell, Adrian Danek, M. Troncoso, Fernando Maldonado, Hans H. Jung, Marcelo Miranda, Jonatan Alvarez Proschle, Rachel Wu-Wallace, Graham Chiu, Patricia Oates, Karin Olsson, S R Angélica Guerrero, Patricio Guerra, Gorka Ochoa‐Garay, Leo Young, Emelie McFarland
article en
2 citations

Abstract

XK disease is a very rare, multi-system disease, which can present with a wide spectrum of symptoms. This disorder can also be identified pre-symptomatically with the incidental detection of serological abnormalities when typing erythrocytes in peripheral blood, or on other routine laboratory testing. Increasing awareness of this disorder and improved access to genetic testing are resulting in increasing identification of affected patients and families. Here we provide updates to some previously-reported families and patients and provide additional clinical details. We also report four new cases with a variety of presentations, one of whom had a novel mutation.

Frontiers in NeuroscienceVol. 18
Karolinska University Hospital (SE), New York Blood Center (US), University of Dundee (GB), Swiss Red Cross (CH), Karolinska Institutet (SE), LMU Klinikum (DE), San Sebastián University (CL), Fraunhofer Chile Research Foundation (CL), Instituto de Salud Pública de Chile (CL), Unity Health System (US), University Hospital of Zurich (CH), Palmerston North Hospital (NZ), W. G. (Bill) Hefner VA Medical Center (US), James J. Peters VA Medical Center (US), Film Independent (US), Center for Neurosciences (US), Clínica MEDS (Chile) (CL), Universidad de Los Lagos (CL), Hospital San Borja Arriarán (CL), Wake Forest University (US), University of Chile (CL), Ludwig-Maximilians-Universität München (DE), Icahn School of Medicine at Mount Sinai (US)
Good health and well-being
Openalex Percentile: Top 29%
Erythrocyte Function and Pathophysiology
0.65
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.